FDA Outlines Statistical Methods for Clinical Trials with Multiple Endpoints

Drug Industry Daily
A A
The FDA issued a draft guidance urging sponsors to work to control error rates before launching clinical trials with multiple endpoints, and provided several examples of appropriate statistical methods.

To View This Article:

Login

Subscribe To Drug Industry Daily